Faron, etusivu

releases and announcements

Results of Placing & Issue of Equity

Regulatory

Faron hosts R&D Day today in London

Regulatory

Proposed Placing to raise up to £15m

Regulatory

Second Traumakine manufacturing site established

Regulatory

Faron Announces Clevegen Grant of European Patent

Regulatory

FDA grants Fast Track Designation for Traumakine®

Regulatory

FDA approval of Faron's Traumakine® IND

Regulatory

INFORAAA trial receives recommendation from IDMC

Regulatory

Faron announces R&D Day in February 2018

Regulatory

Recruitment completed in Traumakine INTEREST Trial

Regulatory
PreviousNext
Back to top